HOJNÁ, S., RAUCHOVÁ, H., MALÍNSKÁ, H., MARKOVÁ, I., HÜTTL, M., PAPOUŠEK, F., BEHULIAK, M., MIKLÁNKOVÁ, D., VAŇOURKOVÁ, Z., NECKÁŘ, J., KADLECOVÁ, M., KUJAL, P., ZICHA, J., VANĚČKOVÁ, I. Antihypertensive and metabolic effects of empagliflozin in Ren-2 transgenic rats, an experimental non-diabetic model of hypertension. Biomedicine & Pharmacotherapy. 2021, 144(Dec), 112246. ISSN 0753-3322. E-ISSN 1950-6007. Dostupné z: https://doi.org/10.1016/j.biopha.2021.112246.